Evidence map›Paper›PMID 41535222›Full record

SynthesisBritish journal of haematology2026

Prognostic role of PET/CT volumetric parameters in paediatric Hodgkin lymphoma: A systematic review and expert recommendations from the International SEARCH for CAYAHL Group.

S Claire Gowdy, Jamie E Flerlage, Jennifer Seelisch, Monica Palese, Tyler Bradshaw, Sharon M Castellino, Steve Cho, Karin Dieckmann, Bradford S Hoppe, Scott Howard and 13 more

Abstract readSystematic Review
In one paragraph

Synthesis in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

S Claire GowdyDepartment of Radiology, BC Children's Hospital and the University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0009-0008-8054-0635
Jamie E FlerlageDivision of Pediatric Hematology/Oncology, Department of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA.ORCID https://orcid.org/0000-0002-4182-9355
Jennifer SeelischChildren's Hospital London Health Sciences Centre, Department of Pediatrics, Western University, London, Canada.
Monica PaleseDivision of Pediatric Hematology/Oncology, Department of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA.
Tyler BradshawDepartment of Radiology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Sharon M CastellinoDepartment of Pediatrics, Emory University School of Medicine and Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Steve ChoDepartment of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Karin DieckmannDepartment of Radiation Oncology, Medical University of Vienna, Vienna, Austria.
Bradford S HoppeMayo Clinic, Jacksonville, Florida, USA.ORCID https://orcid.org/0000-0002-2312-5418
Scott HowardUniversity of Tennessee Health Science Center, Memphis, USA.
Kara M KellyDepartment of Pediatrics, Roswell Park Comprehensive Cancer Center, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
Lars KurchDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Hollie A LaiDepartment of Radiology, Children's Health of Orange County, Orange, California, USA.
Egesta LopciNuclear Medicine Unit, IRCCS-Humanitas Research Hospital, Rozzano, Milano, Italy.
John T LucasDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Christine Mauz-KörholzPediatric Hematology and Oncology, Justus-Liebig-University of Giessen, Giessen, Germany.
Kathleen M McCartenQuality Assurance Review Center (QARC)/Imaging and Radiation Oncology Core Group (IROC), Lincoln, Rhode Island, USA.
Neeta Pandit-TaskarDepartment of Radiology and Nuclear Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Heiko SchöderMolecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Jonas SteglichDepartment of Diagnostic and Interventional Radiology, Heart Center Leipzig, Leipzig, Germany.
Dietrich StoevesandtDepartment of Radiology, University Hospital Halle (Saale), Halle (Saale), Germany.ORCID https://orcid.org/0000-0001-5105-4488
Stephan D VossDepartment of Radiology, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Sarah A MilgromDepartment of Radiation Oncology, University of Colorado, Aurora, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

In adults with classic Hodgkin lymphoma (cHL), metabolic tumour volume (MTV) is valuable for risk stratification. This systematic review explored the role of volumetric parameters in children, adolescents and young adults (CAYA) with cHL. This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) method. Five databases were searched on 16 October 2024. Eligible studies were peer-reviewed manuscripts, written in English, published since database inception that included patients ≤21 years of age with a diagnosis of cHL treated with chemotherapy ± radiotherapy with a baseline

Indexed as

Hodgkin DiseasePositron Emission Tomography Computed TomographyAdolescentChildFluorodeoxyglucose F18HumansPrognosisTumor BurdenYoung AdultFluorodeoxyglucose F18adolescents and young adultschildrenHodgkin lymphomametabolic tumour volumePET/CT

Identifiers

PMID41535222
PMCPMC13071483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.